APFID

Home > Latest News on ID > Interesting Papers

LOGIN
Prevalence and clinical implications of Staphylococcus aureus with a vancomycin MIC of 4 microg/ml in Korea. Microb Drug Resist. 2006 Spring;12(1):33-8.
Date: 2012-02-24   Read: 173576




Microb Drug Resist. 2006 Spring;12(1):33-8.



Prevalence and clinical implications of Staphylococcus aureus with a vancomycin MIC of 4 microg/ml in Korea.



Kim HB, Lee YS, Kim BS, Cha JO, Kwon SU, Lee HJ, Suh JT, Rheem I, Kim JM, Shin BM, Kim MN, Lee K, Lee CS, Kim EC, Oh MD, Choe KW.





Source



Department of Microbiology, National Institute of Health, Seoul 122-701, Republic of Korea.





Abstract



In addition to vancomycin-intermediate Staphylococcus aureus (VISA), S. aureus with a vancomycin MIC of 4 microg/ml has been reported to be the cause of therapeutic failure. This study was designed to determine the prevalence of methicillin-resistant S. aureus (MRSA) with a vancomycin MIC of 4 microg/ml and to clarify the clinical characteristics of infections caused by these isolates. During the 8-week period from April to May, 2001, 27 hospitals participated in a nationwide surveillance program for VISA and vancomycin-resistant S. aureus (VRSA) in Korea. After screening on brain-heart infusion agar containing 4 microg/ml of vancomycin as previously described, 100 isolates with confluent growth were tested. The medical records of the patients involved were reviewed. Even though VISA or VRSA was not detected among 3,756 MRSA isolates, 18 (0.5%) had a vancomycin MIC of 4 microg/ml. The infections in 12 of these patients, excluding 5 that were colonized, were 8 chronic osteomyelitis, 1 surgical site infection, 1 pneumonia, 1 intra-abdominal infection, and 1 catheter-related infection. Although 11 cases were exposed to glycopeptides for a long time (median 56 days), the site of infection became culture-negative in only 1 case. Two patients died of their S. aureus infections. MRSA with a vancomycin MIC of 4 microg/ml was rare. Chronic osteomyelitis was the most common type of infection, and prolonged exposure to glycopeptides was associated with reduced susceptibility to vancomycin.



Next Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: proposal for a new definition. Clin Infect Dis. 2012-02-29 173096
Previous Molecular Epidemiology over an 11-Year Period (2000 to 2010) of Extended-Spectrum 棺-Lactamase-Producing Escherichia coli Causing Bacteremia in a Centralized Can 2012-02-15 173726
익스플로러,사파리,크롬,파이어폭스,오페라에서 작동함
| More
퀵메뉴바로가기 맨위로가기